Biological variation estimates of direct and indirect LDL cholesterol by Friedewald and Martin-Hopkins formulas in healthy individuals

Understanding biological variation (BV) is crucial for accurate clinical decision-making and for establishing analytical quality standards. This study established the BV of low-density lipoprotein cholesterol (LDL-C), assessed using both direct measurement and calculated values obtained from the Friedewald and Martin-Hopkins formulas in healthy individuals. A total of twenty-six healthy Turkish subjects (15 females and 11 males) underwent fasting LDL-C measurement, along with calculated LDL-C derived from serum cholesterol, triglycerides, and high-density lipoprotein cholesterol, using samples collected concurrently on 10 weekly occasions. All measurements were conducted in duplicate by the enzymatic colorimetric method. Within-subject (CV<sub>I</sub>) and between-subject (CV<sub>G</sub>) BV estimates, with 95% confidence intervals (CI), were determined by CV-ANOVA following evaluation of trends, homogeneity of variance, and outlier removal. No significant gender-related differences were observed in the BV components for either direct or calculated LDL-C. According to direct LDL-C, Friedewald LDL-C, and Martin Hopkins LDL-C, CV<sub>I</sub> values were 8.7%, 9.3% and 9.0%, and the CV<sub>G</sub> values were 14.7% for direct LDL-C, 18.5% for Friedewald LDL-C, 18.6% for Martin Hopkins LDL-C. These values supported the use of updated analytical performance specifications and reference change values (RCV). All LDL-C exhibited marked individuality (II < 0.6). By applying a rigorously standardized experimental protocol, the inter-individual variability observed supports the preferred use of RCVs over conventional population-based reference intervals for serial monitoring. These results have important implications for enhancing the clinical utility of LDL-C measurements, regarding cardiovascular risk assessment and individualized therapeutic decision-making.

Authors

Institutions

Publication Details

Journal
Scandinavian Journal of Clinical and Laboratory Investigation
Published
2025-12-24
DOI
https://doi.org/10.1080/00365513.2025.2605638
Primary Topic
Diabetes, Cardiovascular Risks, and Lipoproteins
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Biological variation estimates of direct and indirect LDL cholesterol by Friedewald and Martin-Hopkins formulas in healthy individuals

Filiz Alkan Baylan, Esin Avcı, Mehmet Özcan, Şerif Ercan et al.
Scandinavian Journal of Clinical and Laboratory Investigation
Diabetes, Cardiovascular Risks, and Lipoproteins
article

Biological variation estimates of direct and indirect LDL cholesterol by Friedewald and Martin-Hopkins formulas in healthy individuals

Filiz Alkan Baylan, Esin Avcı, Mehmet Özcan, Şerif Ercan, Müjgan Ercan, Ayşe Ciriz
article en

Abstract

Understanding biological variation (BV) is crucial for accurate clinical decision-making and for establishing analytical quality standards. This study established the BV of low-density lipoprotein cholesterol (LDL-C), assessed using both direct measurement and calculated values obtained from the Friedewald and Martin-Hopkins formulas in healthy individuals. A total of twenty-six healthy Turkish subjects (15 females and 11 males) underwent fasting LDL-C measurement, along with calculated LDL-C derived from serum cholesterol, triglycerides, and high-density lipoprotein cholesterol, using samples collected concurrently on 10 weekly occasions. All measurements were conducted in duplicate by the enzymatic colorimetric method. Within-subject (CV<sub>I</sub>) and between-subject (CV<sub>G</sub>) BV estimates, with 95% confidence intervals (CI), were determined by CV-ANOVA following evaluation of trends, homogeneity of variance, and outlier removal. No significant gender-related differences were observed in the BV components for either direct or calculated LDL-C. According to direct LDL-C, Friedewald LDL-C, and Martin Hopkins LDL-C, CV<sub>I</sub> values were 8.7%, 9.3% and 9.0%, and the CV<sub>G</sub> values were 14.7% for direct LDL-C, 18.5% for Friedewald LDL-C, 18.6% for Martin Hopkins LDL-C. These values supported the use of updated analytical performance specifications and reference change values (RCV). All LDL-C exhibited marked individuality (II < 0.6). By applying a rigorously standardized experimental protocol, the inter-individual variability observed supports the preferred use of RCVs over conventional population-based reference intervals for serial monitoring. These results have important implications for enhancing the clinical utility of LDL-C measurements, regarding cardiovascular risk assessment and individualized therapeutic decision-making.

Scandinavian Journal of Clinical and Laboratory InvestigationVol. 86(1)
Zonguldak Bülent Ecevit University (TR), Necmettin Erbakan University (TR), National Public Health Laboratory (NP), Public Health Laboratory, Pamukkale University (TR), Afyon Kocatepe University (TR), Luhansk State Medical University (UA)
Peace, Justice and strong institutions, Gender equality
Openalex Percentile: Top 30%
Diabetes, Cardiovascular Risks, and Lipoproteins
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.